Bristol Myers Squibb Co. Stock Outperforms Competitors Despite Losses On The Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. (BMY) slumped 0.24% to $72.14 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 1.56% to 3,928.86 and Dow Jones Industrial Average falling 1.81% to 33,296.96. This was the stock's second consecutive day of losses. Bristol Myers Squibb Co. closed $9.30 below its 52-week high ($81.44), which the company achieved on December 1st.
Despite its losses, the stock outperformed some of its competitors Wednesday, as Johnson & Johnson (JNJ) fell 1.51% to $169.76, Pfizer Inc. (PFE) fell 2.34% to $45.00, and Abbott Laboratories (ABT) fell 1.66% to $111.51.true Trading volume (8.3 M) remained 775,043 below its 50-day average volume of 9.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 18, 2023.
(END) Dow Jones Newswires
January 18, 2023 16:41 ET (21:41 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.